ADVISORY-Alerts incorrectly sourced to Arcturus Therapeutics withdrawn

Reuters
Aug 29
ADVISORY-Alerts incorrectly sourced to Arcturus <a href="https://laohu8.com/S/LENZ">Therapeutics</a> withdrawn

Alerts incorrectly attributed to Arcturus Therapeutics ARCT.O about Meiji Seika Pharma getting approval for the KOSTAIVE MRNA vaccine in Japan have been withdrawn. Meiji has an ongoing agreement for distribution and sales in Japan of Arcturus' KOSTAIVE, a vaccine candidate against COVID-19.

There will be no substitute.

STORY_NUMBER:nFWN3UK22T

STORY_DATE:29/08/2025

STORY_TIME:[10:11:05 AM GMT]

((bangalore.newsroom@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10